This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Free Reports

Lundbeck to Buy Chelsea Therapeutics for $658M

Central nervous system disorder specialist Chelsea Therapeutics International on Thursday said it had signed up to a bid from Denmark's H. Lundbeck that values its stock at up to $658 million.

Page 1 of 1
< Previous
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs